Molnupiravir 200 mg Capsules

Home - - Molnupiravir 200 mg Capsules

Molnupiravir 200 mg Capsules

MOLNUVID 200 mg Exporter
Active Ingredient :
Manufacturer :
Healing Pharma
Form :
Packing :
Strength :
200 mg


Molnupiravir Manufacturer

Molnupiravir (development codes MK-4482 and EIDD-2801) is an orally active experimental antiviral medication that was designed to treat viruses. It is a class of drug of the synthetic nucleoside derivative N4-hydroxycytidine that works against viruses by causing copying errors during viral RNA replication.

Mild Covid patients benefit from molnupiravir (molnuvid 200 mg)because it speeds up their recovery.


Molnupiravir Benefits

  • Drastically reduce the number of days you’re infected.
  • Stop the infection from spreading and causing COVID-19 problems and consequences.
  • Suppress Coronavirus transmission and slow the spread of the virus in the community.

Healing Pharma is one of the major wholesale and retail distributors of life-saving generic drugs for Hepatitis C, Hepatitis B, HIV, Cancer, and liver transplantation. The organization, which is based in Mumbai, India’s financial centre, has been in operation for more than 10 years and is led by a team of highly qualified individuals. Our pharmaceutical products are currently exported to over more than 15 countries, meeting the needs of a wide range of therapeutic needs.

We have successfully dispatched over 10,000 parcels for hepatitis c patients across 15 nations in a very short period of time by accentuating and assuring the patient’s needs are our top priority. Healing Pharma is a government-approved pharmaceutical manufacturer and bulk pharma exporter with all required licenses in place.

Healing Pharma is a pharmaceutical manufacturer, pharmaceutical bulk cargo exporter, bulk pharmaceutical exporter, and medicine supplier with operations in Brazil, Cambodia, Venezuela, the Philippines, Nigeria, Seychelles, and Sudan. Molnupiraivir is an antiviral that has the ability to target other viral infections. It also helps in covid 19.